Literature DB >> 2937138

Rheumatoid synovial dendritic cells as stimulators in allogeneic and autologous mixed leukocyte reactions--comparison with autologous monocytes as stimulator cells.

K Waalen, J Thoen, O Førre, T Hovig, J Teigland, J B Natvig.   

Abstract

Dendritic cells were isolated from peripheral blood, synovial fluid, and synovial tissue of patients with rheumatoid arthritis and from peripheral blood of healthy blood donors on the basis of semiadherence to plastic surfaces. The cells were compared with autologous peripheral blood monocytes with respect to their stimulating capacities in allogeneic and autologous mixed leukocyte reactions (MLR). Dendritic cells from the various compartments stimulated allogeneic T cells 6-14 times more than monocytes did. Dendritic cells also stimulated autologous T cells 10-24 times more than monocytes did. Evidence in favour of the dendritic cell as the major stimulating cell type in MLR was also found in mixed experiments in which various ratios of dendritic cells and monocytes were used as stimulator cells. Furthermore, the activating structures on the dendritic cells seem to be major histocompatibility complex class II antigens, since anti-HLA-DR antibodies inhibited the responses. The results, especially from the autologous MLR, indicate that dendritic cells are important accessory cells for the various immune responses in rheumatoid inflammation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2937138     DOI: 10.1111/j.1365-3083.1986.tb01962.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  17 in total

1.  Human rheumatoid synovial and normal blood dendritic cells as antigen presenting cell--comparison with autologous monocytes.

Authors:  K Waalen; O Førre; J Teigland; J B Natvig
Journal:  Clin Exp Immunol       Date:  1987-10       Impact factor: 4.330

2.  Isolation and characterization of dendritic cells from adenoids of children with otitis media with effusion.

Authors:  E B van Nieuwkerk; S van der Baan; C D Richters; E W Kamperdijk
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

3.  Increased nitric oxide (NO) production by antigen-presenting dendritic cells is responsible for low allogeneic mixed leucocyte reaction (MLR) in primary biliary cirrhosis (PBC).

Authors:  K Yamamoto; S M Akbar; T Masumoto; M Onji
Journal:  Clin Exp Immunol       Date:  1998-10       Impact factor: 4.330

Review 4.  Antigen-presenting cells in rheumatoid arthritis.

Authors:  R Thomas
Journal:  Springer Semin Immunopathol       Date:  1998

5.  Dendritic cells and IFN-alpha-producing cells are two functionally distinct non-B, non-monocytic HLA-DR+ cell subsets in human peripheral blood.

Authors:  J Chehimi; S E Starr; H Kawashima; D S Miller; G Trinchieri; B Perussia; S Bandyopadhyay
Journal:  Immunology       Date:  1989-12       Impact factor: 7.397

Review 6.  Dendritic cells in rheumatoid inflammation.

Authors:  K Waalen; O Førre; J B Natvig
Journal:  Springer Semin Immunopathol       Date:  1988

7.  Functional characterization of SV40-transformed adherent synovial cells from rheumatoid arthritis.

Authors:  M Goto; M Okamoto; M Sasano; K Nishizawa; S Aotsuka; N Yamaguchi; M Obinata; K Ikeda
Journal:  Clin Exp Immunol       Date:  1991-12       Impact factor: 4.330

8.  Spontaneous production of an interleukin 1-like factor by cloned rheumatoid synovial cells in long-term culture.

Authors:  M Goto; M Sasano; H Yamanaka; N Miyasaka; N Kamatani; K Inoue; K Nishioka; T Miyamoto
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

Review 9.  The B cell system in the rheumatoid inflammation. New insights into the pathogenesis of rheumatoid arthritis using synovial B cell hybridoma clones.

Authors:  J B Natvig; I Randen; K Thompson; O Førre; E Munthe
Journal:  Springer Semin Immunopathol       Date:  1989

Review 10.  Dendritic cells in the pathogenesis of rheumatoid arthritis.

Authors:  L M March
Journal:  Rheumatol Int       Date:  1987       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.